---
title: "Spatial risk modeling forecasts US measles re-emergence and guides targeted vaccination"
id: "medrxiv-8-epidemiologic-shifts-predict-spatial-patterns-of-measles-re-emergence-in-the"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-8-epidemiologic-shifts-predict-spatial-patterns-of-measles-re-emergence-in-the"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.14.26365590v1?rss=1"
published_at: "2026-10-16T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Spatial risk modeling forecasts US measles re-emergence and guides targeted vaccination
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-8-epidemiologic-shifts-predict-spatial-patterns-of-measles-re-emergence-in-the
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.14.26365590v1?rss=1)
- **Published At:** 2026-10-16T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The authors analyzed annual county-level **measles** cases and **vaccine coverage** in the United States from 2011–2025 to characterize re-emergence dynamics. - Data indicated an epidemiologic shift: from 2011–2020 outbreaks were weakly linked to county vaccine coverage and remained largely isolated to single counties. - From 2021–2025, the study team observed a stronger association between county-level vaccine coverage and outbreak size, and increased spread across neighboring counties. - Investigators developed a spatial statistical model that predicted counties with ≥10 cases; validation over 2021–2025 showed sensitivity 95% (range 75–100%) and specificity 83% (range 64–98%). - The authors reported that mechanistic models using county vaccine coverage alone performed worse, particularly for predicting larger outbreaks. - Using the spatial model, prioritizing interventions in the top decile of model-predicted risk outperformed state-level targeting or selection by low coverage alone. - The study team estimated that a modest 5 percentage point increase in vaccine coverage in counties in the top-risk decile reduced long-term national measles risk by over 90%. - Outbreak risk remained spatially concentrated even as transmission became more sustained across broader populations rather than confined to socially clustered communities. - Data and code are available via a public GitHub repository; requests for identifiable measles case data must be obtained from the authors. - The study received Stanford IRB approval and the authors declared no competing interests.
## Clinical Analysis & Structured Key Points
[Skip to main content](https://www.medrxiv.org/content/10.64898/2026.10.14.26365590v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Epidemiologic shifts predict spatial patterns of measles re-emergence in the United States [ View ORCID Profile](http://orcid.org/0000-0003-1542-8643)Chirag K Kumar, Lauren A Stoffel, Joshua L Warren, Seth Blumberg, Robert Schechter, Kate M Bubar, Mustafa Fattah, Mathew V Kiang, Yvonne Maldonado, Erin A Mordecai, Peter J Hotez, Marc Lipsitch, [ View ORCID Profile](http://orcid.org/0000-0002-5407-2005)Nathan C Lo doi: https://doi.org/10.64898/2026.10.14.26365590 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Chirag K Kumar 1 Stanford University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Chirag%2BK%2BKumar%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kumar%20CK&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AChirag%2BK%2BKumar%2B) * [ORCID record for Chirag K Kumar](http://orcid.org/0000-0003-1542-8643 "Open in new tab") Lauren A Stoffel 1 Stanford University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Lauren%2BA%2BStoffel%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Stoffel%20LA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALauren%2BA%2BStoffel%2B) Joshua L Warren 2 Yale University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Joshua%2BL%2BWarren%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Warren%20JL&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJoshua%2BL%2BWarren%2B) Seth Blumberg 3 University of California, San Francisco; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Seth%2BBlumberg%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Blumberg%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASeth%2BBlumberg%2B) Robert Schechter 4 California Department of Public Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Robert%2BSchechter%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Schechter%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARobert%2BSchechter%2B) Kate M Bubar 1 Stanford University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Kate%2BM%2BBubar%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Bubar%20KM&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AKate%2BM%2BBubar%2B) Mustafa Fattah 5 Columbia University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mustafa%2BFattah%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Fattah%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMustafa%2BFattah%2B) Mathew V Kiang 1 Stanford University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mathew%2BV%2BKiang%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kiang%20MV&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMathew%2BV%2BKiang%2B) Yvonne Maldonado 1 Stanford University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yvonne%2BMaldonado%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Maldonado%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYvonne%2BMaldonado%2B) Erin A Mordecai 1 Stanford University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Erin%2BA%2BMordecai%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Mordecai%20EA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AErin%2BA%2BMordecai%2B) Peter J Hotez 6 Baylor College of Medicine * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Peter%2BJ%2BHotez%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hotez%20PJ&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APeter%2BJ%2BHotez%2B) Marc Lipsitch 1 Stanford University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Marc%2BLipsitch%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Lipsitch%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMarc%2BLipsitch%2B) Nathan C Lo 1 Stanford University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Nathan%2BC%2BLo%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Lo%20NC&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANathan%2BC%2BLo%2B) * [ORCID record for Nathan C Lo](http://orcid.org/0000-0002-5407-2005 "Open in new tab") * For correspondence: nathan.lo@stanford.edu * [Abstract](https://www.medrxiv.org/content/10.64898/2026.10.14.26365590v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1323714/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.10.14.26365590v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1323714/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.10.14.26365590v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1323714/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.10.14.26365590v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1323714/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.10.14.26365590v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1323714/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.10.14.26365590v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1323714/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Globally, measles is re-emerging in countries that have previously achieved elimination, including the United States. As immunization rates decline, characterizing the dynamics and evolving spatial pattern of measles re-emergence is critical to inform the public health response. We analyze annual county-level measles cases and vaccine coverage data in the United States (US) from 2011-2025 and find a shift in measles epidemiology in recent years indicative of re-emergence. While outbreak risk is spatially concentrated, we find that outbreaks are increasingly spreading throughout the broader population and across counties, but targeted interventions are predicted to prevent re-emergence nationwide. During the first decade of this period (2011-2020), outbreaks were only weakly associated with county-level vaccine coverage and predominantly isolated to single counties; however, recently (2021-2025), vaccine coverage has become strongly associated with outbreak size and spread across neighboring counties has increased. These findings suggest that measles transmission is increasingly sustained across the broader population rather than only in socially clustered communities. We developed a spatial statistical model to predict outbreak risk and size in all US counties with validation over 2021-2025; the model predicted counties with ≥10 cases with a sensitivity of 95% (range across 2021-2025: 75-100%) and specificity of 83% (64-98%). Mechanistic models based on county vaccine coverage alone had worse performance, particularly in predicting larger outbreaks. Using the spatial statistical model, we find that prioritizing interventions in the areas of greatest model-predicted risk (e.g., top decile of US counties) was more impactful than state-level interventions (e.g., top five states) or targeting based on low vaccine coverage alone. Achieving even modest (5 percentage point) increases in vaccine coverage in counties in the top decile of model-predicted risk reduced long-term measles risk nationwide by over 90%. Together, these findings demonstrate that predictive risk modeling to inform spatially targeted interventions can likely mitigate the re-emergence of vaccine-preventable diseases. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study was approved by the Stanford University Institutional Review Board. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability Study data that are not considered identifiable are available online in the GitHub repository. Requests for measles case data, which are not publicly posted due to potential identifiability concerns, can be obtained from the authors. ## Funder Information Declared National Institutes of Health, DP2AI17085, T32AI007502, R35GM133439, R01DA060716, R35GM147702 U.S. National Science Foundation, DGE-2146755 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.10.14.26365590v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.02.25.26346992v2 "Novel adenoma-immune phenotypes are associated with risk of metachronous polyps and colorectal cancer in a bowel screening cohort")[Next ](https://www.medrxiv.org/content/10.64898/2026.10.14.26365593v1 "Factors associated with poor glycaemic control among children and adolescents with Type 1 Diabetes Mellitus at a tertiary hospital in Kenya") Posted October 16, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.10.14.26365590v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/10/16/2026.10.14.26365590.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.10.14.26365590v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.10.14.26365590v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/10/16/2026.10.14.26365590.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Epidemiologic shifts predict spatial patterns of measles re-emergence in the United States Chirag K Kumar, Lauren A Stoffel, Joshua L Warren, Seth Blumberg, Robert Schechter, Kate M Bubar, Mustafa Fattah, Mathew V Kiang, Yvonne Maldonado, Erin A Mordecai, Peter J Hotez, Marc Lipsitch, Nathan C Lo medRxiv 2026.10.14.26365590; doi: https://doi.org/10.64898/2026.10.14.26365590 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.14.26365590v1%26text%3DEpidemiologic%2520shifts%2520predict%2520spatial%2520patterns%2520of%2520measles%2520re-emergence%2520in%2520the%2520United%2520States "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.14.26365590v1%26t%3DEpidemiologic%2520shifts%2520predict%2520spatial%2520patterns%2520of%2520measles%2520re-emergence%2520in%2520the%2520United%2520States "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.14.26365590v1%26title%3DEpidemiologic%2520shifts%2520predict%2520spatial%2520patterns%2520of%2520measles%2520re-emergence%2520in%2520the%2520United%2520States%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.14.26365590v1%26title%3DEpidemiologic%2520shifts%2520predict%2520spatial%2520patterns%2520of%2520measles%2520re-emergence%2520in%2520the%2520United%2520States "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.10.14.26365590) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.10.14.26365590v1&count=horizontal&via=&text=Epidemiologic%20shifts%20predict%20spatial%20patterns%20of%20measles%20re-emergence%20in%20the%20United%20States&counturl=www.medrxiv.org/content/10.64898/2026.10.14.26365590v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (629) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (914) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (343) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4926) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (488) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (422) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (667) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1658) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16131) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (35) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1229) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7175) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (740) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1081) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5190) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1453) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-a
## Related Clinical Research

- [Beyond conventional biomarkers: editorial on novel biomarkers and combinatorial approaches for imm](https://medichelpline.com/clinical-feed/frontiers-in-immunology-16-editorial-beyond-conventional-biomarkers-unlocking-immunotherapy-response.md)
- [Soluble urokinase plasminogen activator receptor (suPAR) across the kidney–cardiometabolic continu](https://medichelpline.com/clinical-feed/frontiers-in-immunology-17-soluble-urokinase-plasminogen-activator-receptor-across-the-kidney.md)
- [Persistent Borrelia burgdorferi Antigen in CD14⁺CD16⁺ Monocytes Linked to Immune Remodeling in PTL](https://medichelpline.com/clinical-feed/medrxiv-0-persistent-borrelia-burgdorferi-protein-antigen-in-cd16-monocytes-is-associated.md)
- [Insulin-binding B cells emerge in early-stage type 1 diabetes without somatic hypermutation or aut](https://medichelpline.com/clinical-feed/biorxiv-3-insulin-binding-b-cells-can-arise-in-early-stage-type-1-diabetes-individuals-in.md)
- [PPI Deprescription and 30-Day Clostridioides difficile Risk: Substudy of the MedSafer Trial](https://medichelpline.com/clinical-feed/medrxiv-7-effect-of-proton-pump-inhibitor-deprescription-on-the-risk-of-clostridioides.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.